Carlsmed, Inc. (CARL) income statement
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30120% above fair value
$17.37−0.37 (-2.09%)
Close on Nov 18, 2026Market cap $474.25MP/E –Yield –
Carlsmed, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 76.6%
- Operating margin
- -61.1%
- Net margin
- -57.4%
- Return on equity, FY2025
- -209.9%
Financial strength
- Current ratio
- 8.84
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 373.0%
Valuation
- P/E ratio
- –
- Price to sales
- 7.49
- Price to book
- 5.63
- Dividend yield
- –
See a number that looks wrong?